Greg Fliszar Named Co-Chair to ABA Joint Opioid Task Force

Monday, September 30, 2019

Greg Fliszar has been named a co-chair of the American Bar Association’s Joint Opioid Task Force (Opioid Task Force). The Opioid Task Force comprises leadership from the American Bar Association’s Senior Lawyer Division and Health Law Section to collaborate on confronting the opioid epidemic through programmatic and policy efforts.

Greg focuses his practice on health law and handles a variety of health law litigation and regulatory and compliance matters for a number of different types of health care providers, including hospitals, hospices, and behavioral health providers. He has significant experience with HIPAA and data privacy issues and has counseled insurance company clients on understanding their obligations under the Medicare Secondary Payer Act. Prior to attending law school, Greg worked as a doctoral level clinical psychologist in inpatient and outpatient settings and was a clinical instructor of psychiatry at the MCP-Hahnemann School of Medicine.

Founded in 1878, the American Bar Association is committed to advancing the rule of law across the United States and beyond by providing practical resources for legal professionals, law school accreditation, model ethics codes, and more.

About Cozen O'Connor

Established in 1970, Cozen O’Connor has more than 825 attorneys who help clients manage risk and make better business decisions. The firm counsels clients on their most sophisticated legal matters in all areas of the law, including litigation, corporate, and regulatory law. Representing a broad array of leading global corporations and middle market companies, Cozen O’Connor services its clients’ needs through 31 offices across two continents.



Related Practice Areas

Keep up-to-date with the latest news from Cozen O'Connor

Enter your City or Zip.

Probably shouldn't change this:
Sign up to receive alerts, publications, and event / webinar invites.

By submitting your contact information, you are giving Cozen O'Connor consent to contact you via email.